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Abstract
Microvesicles are plasma membrane-derived vesicles released into the extracellular environment by a variety of cell types.
Originally characterized from platelets, microvesicles are a normal constituent of human plasma, where they play an
important role in maintaining hematostasis. Microvesicles have been shown to transfer proteins and RNA from cell to cell
and they are also believed to play a role in intercellular communication. We characterized the RNA and protein content of
embryonic stem cell microvesicles and show that they can be engineered to carry exogenously expressed mRNA and
protein such as green fluorescent protein (GFP). We demonstrate that these engineered microvesicles dock and fuse with
other embryonic stem cells, transferring their GFP. Additionally, we show that embryonic stem cells microvesicles contain
abundant microRNA and that they can transfer a subset of microRNAs to mouse embryonic fibroblasts in vitro. Since
microRNAs are short (21–24 nt), naturally occurring RNAs that regulate protein translation, our findings open up the
intriguing possibility that stem cells can alter the expression of genes in neighboring cells by transferring microRNAs
contained in microvesicles. Embryonic stem cell microvesicles may be useful therapeutic tools for transferring mRNA,
microRNAs, protein, and siRNA to cells and may be important mediators of signaling within stem cell niches.
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Introduction
Circulating platelet-derived vesicles were first identified in human
plasma in the 1960’s [1]. These vesicles, called microvesicles or
microparticles, are heterogeneous in size and range from ,30 nm
to 1 mm. Previously believed to be inert cellular debris, microvesicles
are now gaining acceptance as important mediators of intercellular
communication [2–9]. For example, microvesicles may mediate
intercellular communication by transporting bioactive lipids,
mRNA, or proteins between cells. Microvesicles have been
identified from many cellular sources including monocytes,
macrophages, endothelial cells, leukocytes, polymorphonuclear
leukocytes, and tumor cells [2,4,5,10]. More recently, microvesicles
were isolated from embryonic stem cells. These embryonic stem cell
microvesicles (ESMVs) were capable of reprogramming hemato-
poietic progenitors [6], suggesting that microvesicles are capable of
providing stem cells with extrinsic cues, which may regulate stem
cell proliferation, and fate in stem cell niches. Shedding of
microvesicles is a normal physiological process and is interestingly
related to high rates of cellular proliferation. Cellular stress and
damage, however, can also result in the release of membrane
microvesicles [7,11–13]. In humans, microvesicles play an essential
role in maintaining hematostasis. A reduction in the number of
platelet microvesicles causes a bleeding disorder called Scott
Syndrome [14]. Elevated levels of microvesicles are also associated
with a variety of disorders including acute coronary syndrome,
hypertension, diabetes, and pulmonary embolism (reviewed in [15]).
In addition to maintaining hematostasis, microvesicles have also
been implicated in carrying membrane bound morphogens in
Drosophila [9], and they may influence the behavior and survival of
hematopoietic progenitors [6,10].
The mechanism by which ESMVs may mediate intercellular
signaling could involve the activation of receptors on the recipient
cell by ligands in the ESMV. In this manner, ESMVs would be
able to carry membrane bound ligands considerable distances
from their stem cell origin. Alternatively, ESMVs may be able to
mediate signaling by the direct transfer of proteins, RNA, or
bioactive lipids to the recipient cell, serving as ‘‘physiological
liposomes’’ [6,7]. If ESMVs can indeed serve as ‘‘physiological
liposomes,’’ transferring RNA and proteins to cells, they can
perhaps be used to deliver exogenously expressed genes for
therapeutic purposes. To explore this possibility, we first
characterized the RNA and protein content of ESMVs and
whether they carry the mRNA and protein expressed from a
transgene present in embryonic stem cells (ESCs) encoding green
fluorescent protein (GFP). We then investigated the ability of
ESMVs to transfer GFP to recipient cells. We also explored the
possibility that ESMVs can transport and transfer microRNAs
(miRNAs) to cells. MiRNAs are a group of small (21–24nt)
noncoding RNAs that regulate gene expression in mammals by
binding to the 39 untranslated region (UTR) of mRNAs to repress
translation [16–18]. miRNAs have been found in peripheral blood
microvesicles of healthy individuals [19] and in ovarian tumor
microvesicles circulating in the peripheral blood of patients [20].
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We show that ESMVs are capable of transferring a subset of
miRNAs to mouse embryonic fibroblasts (MEFs), suggesting a
tightly regulated transfer process. Transfer of miRNAs by
microvesicles represents a novel method of paracrine signaling,
potentially making microvesicles important components of stem
cell niches. It also opens up the possibility of transferring siRNAs
via microvesicles. The delivery of siRNAs by microvesicles may be
particularly useful in the treatment of retinal disorders such as age
related macular degeneration, since injection of naked siRNAs
into the eye may have deleterious effects [19].
Results
ESMV RNA profile
Although ESMVs have been reported to contain mRNA [6],
little was known about their total RNA profile or the quality and
types of RNA that they contain. Thus, we isolated mouse ESMVs
and determined their total RNA profile by gel electrophoresis and
capillary electrophoresis (Figures 1A and 1B). 4.7760.7 mg
(n = 10) of total RNA can be obtained over a 48 hour period
from ESMVs released by 3.56106 ESCs plated on a T175 culture
flask and cultured to ,70% confluence in serum-free media.
Unlike total RNA collected from ESCs, the total RNA from
ESMVs does not contain 28S and 18S rRNA (Figures 1A and 1B).
Instead, the majority of the total RNA in ESMVs is concentrated
below 2 kb, which may represent mRNAs and small RNAs such as
miRNAs.
ESMVs contain mRNA
Consistent with previous studies [6,10,21], we detected the
presence of mRNA in microvesicles. Purified polyA-containing
RNA from ESMVs (0.59%60.2% of total RNA, n= 4) was found
to be less abundant than that present in ESCs (3.43%60.6% of
total RNA, n= 4). To compare the differences in transcript levels
in ESMVs versus ESCs, we performed real time quantitative RT-
PCR using primers shown in Table 1 and SYBR Green for
detection. Interestingly, we observed an overall reduction of
several orders of magnitude in the levels of all transcripts tested
from ESMVs when compared with the levels of the same mRNAs
in ESCs, including that encoding the cytoskeletal protein, b-actin
(Figure 1C). Because of this disparity in expression levels, we could
not use b-actin as a normalizer in comparative quantification
experiments. Instead, we relied on adding equivalent amounts of
RNA template in each experiment. The tested transcripts encoded
transcription factors important for maintaining stem cell pluripo-
tency (oct-4, nanog, and gata-4), cell surface ligands in the notch
signaling pathway (jag-1 and jag-2), and a secreted signaling protein
(wnt-3) (Figure 1D). Bootstrap ANOVA suggested a significant
difference between all groups, F=3.33, p,0.0001. Further
analysis using the 95th percentile confidence interval calculated
for each mRNA revealed differences between several groups
(Figure 1E). Since we observed a reduction in abundance in all
transcripts tested, we expected that mRNAs were overall less
abundant in ESMVs compared with ESCs. However, the
proportion of polyA RNA purified from ESMV and ESC total
RNA (0.59% and 3.43%) reflected a 5.8-fold difference, whereas a
Figure 1. ESMVs contain RNA. ESMV total RNA lacks 28S and 18S
rRNA and consists mostly of RNA below ,2kb. (A) 1.2% denaturing
agarose gel loaded with total RNA from ESMVs (lane 1) and ESCs (lane
2). (B) Digital gel images from capillary electrophoresis of total RNA
from ESMVs (lane 1) and ESCs (lane 2). (C) Real time quantitative RT-PCR
amplification curves for b-actin reveals much less expression in ESMVs
compared with ESCs. (D) The relative abundance of several mRNAs in
ESMVs compared with ESCs was determined by real time quantitative
RT-PCR using the primers shown in Table 1. The mRNAs tested include
gata-4 (lane 1), jag-1 (lane 2), jag-2 (lane 3), nanog (lane 4), oct-4 (lane 5),
wnt-3 (lane 6), and b-actin (lane 7). Box plot of relative abundance of all
mRNA tested in ESMVs compared with ESCs (n = 8). The boxed area
represents the mean6quartile and the whiskers extend out to the
minimum and maximum values. Bootstrap ANOVA was performed and
a significant difference was detected between all groups (p,0.0001).
(E) The 95th percentile confidence interval for each mRNA shown in (D)
was determined and plotted on a bar graph. Non overlapping groups
are significantly different from each other.
doi:10.1371/journal.pone.0004722.g001
Table 1. Primers used for RT-PCR.
Primer pairs Sequence (59–39)
Amplicon
(bp)
Oct-4 59 GCCGGGCTGGGTGGATTCTC 271
ATTGGGGCGGTCGGCACAGG
Oct-4 39 AGGCCCGGAAGAGAAAGCGAACTA 265
TGGGGGCAGAGGAAAGGATACAGC
GFP 59 ATGGTGAGCAAGGGCGAGGAG 274
CTTCGGGCATGGCGGACTTGA
GFP 39 TATCATGGCCGACAAGCAGAAGAACG 230
CGGCGGCGGTCACGAACTCC
GFP end-point GTCCAGGAGCGCACCATCTTCTT 406
CGGCGGCGGTCACGAACT
Nanog TCCAGAAGAGGGCGTCAGAT 283
CTTTGGTCCCAGCATTCAGG
b-actin TTGTTACCAACTGGGACGACA 350
TCTTCATGAGGTAGTCTGTCA
Gata-4 AGGCGAGATGGGACGGGACACTAC 202
CGCAGGCATTACATACAGGCTCAC
Wnt-3 CTTCATGATCGCCGGCAAACTTC 189
TGGGATGGAGCCGCAGAGCAGAG
Jag-1 CAGTGCCTCTGTGAGACCAAC 193
AGGGGTCAGAGAGACAAGCATG
Jag-2 GCAAAGAATGCAAAGAAGCC 233
TGGCTGCCACAGTAGTTCAGG
doi:10.1371/journal.pone.0004722.t001
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much larger reduction of at least 55-fold was observed with all
transcripts tested by quantitative RT-PCR.
ESMVs contain protein
Consistent with previous reports, abundant protein can be
isolated from ESMVs. We obtained 25.864.5 mg (n = 3) of total
protein from ESMVs released over a 48 hour period by 3.56106
ESCs originally plated on a T175 culture flask and cultured to
,70% confluence in serum-free media. We digested microvesicles,
pelleted the insoluble fraction, TCA precipitated the soluble
proteins and separated both insoluble and soluble proteins by
SDS-PAGE. Several distinct bands were present in ESMVs and
not in the media controls suggesting that ESMVs may contain a
subset of abundant proteins (Figure 2).
ESMVs contain mRNA and protein expressed from a
transgene in ESCs encoding GFP
We investigated whether ESMVs also contain mRNA and
protein expressed from a GFP transgene present in ESCs. We
isolated ESMVs from this GFP-expressing ESC line, performed
RT-PCR with their RNA, and verified the presence of GFP
mRNA (Figure 3A). The relative abundance of GFP mRNA in
ESMVs versus ESCs was quantified by real time quantitative RT-
PCR (Figure 3B) using primers shown in Table 1. The relative
abundance of GFP mRNA in ESMVs was comparable to that of
several of the endogenous transcripts tested (Figures 1D and 3B).
In order to determine if GFP (protein) was also present in
ESMVs, proteins in ESCs and ESMVs were isolated, separated by
PAGE, and transferred to a blot that was incubated with a
polyclonal antibody against GFP. GFP was readily detected in
ESMVs, although it was less abundant than in ESCs (Figure 3C).
RNA integrity is maintained in ESMVs
To confirm the integrity of the mRNA isolated from ESMVs,
we used real time quantitative RT-PCR to determine the ratio of
59 amplicons to 39 amplicons of individual transcripts; ideally, the
59:39 amplicon ratio should equal 1 if there is no degradation.
However, RT inefficiencies and small errors in the calculated PCR
primer efficiencies can generate 59:39 ratios that deviate from 1.
mRNA isolated from ESCs was used as control, and its quality was
verified by determining the 28S:18S rRNA ratio, which was .1.9
in all of our preparations (indicating minimal degradation). Real
time quantitative RT-PCR was carried out to compare the 59:39
ratio for ESMVs and ESCs for two transcripts, oct-4 which has an
average size (1.3 kb), and GFP which is exogenously expressed in
these ESCs. Our results indicated that the mRNA in ESMVs is
intact and not degraded (Figures 4A and 4B). Bootstrap t-tests used
to compare the ESC 59:39 groups with the ESMV 59:39 groups for
each mRNA showed no significant difference after 10,000
bootstrap resamplings for either oct-4, p=0.495 or GFP, p=0.517.
ESMVs contain miRNAs
Based on the total RNA profile (Figures 1A and 1B) and since
mRNAs make up a small percentage of total RNA in ESMVs, a
significant portion of RNA in ESMVs may be composed of small
RNAs. We hypothesized that ESMVs contain abundant miRNAs
in addition to mRNA. Using RT-PCR, we tested for the presence
of a ubiquitous miRNA, miR-16, which is expressed in ESCs. Since
mature miRNAs are very short transcripts, a strategy which uses a
stem-loop RT primer was used [22]. Total RNA from ESMVs was
isolated using two different methods: the mirVana miRNA
isolation kit (Ambion) retains small RNAs, whereas the Nucleospin
Figure 2. ESMVs contain protein. Insoluble and soluble protein
fractions were isolated from ESMVs and separated on a Tris-glycine
buffered 4–20% SDS-polyacrylamide gel, stained with SYPRO Ruby Red.
(A) The insoluble protein fraction. Lanes: (1) control medium, (2) ESMVs.
(B) The soluble protein fraction after precipitation with TCA. Lanes: (1)
control medium, (2) ESMVs. Equivalent amounts of sample and control
medium were processed.
doi:10.1371/journal.pone.0004722.g002
Figure 3. ESMVs contain GFP mRNA and protein expressed from a GFP transgene in ESCs. (A) 300 ng of ESMV RNA from an ESC line
expressing GFP were used for RT, and 35 cycles of PCR amplification were performed with the GFP primers shown in Table 1. A 2% agarose gel was
loaded with the RT-PCR products from ESMVs (lane 1), ESCs (lane 2), and a ‘‘no RT’’ control of ESMVs (lane 3). A 406bp band corresponding to the GFP
amplicon is observed in both the ESMV and ESC lanes. (B) (Left) Box plot of relative abundance of GFP in ESMVs compared with ESCs (n = 8). (Right)
Comparison of amplification curves for GFP (top) and b-actin (bottom) in ESCs (1) and ESMVs (2). Note that while quantitative RT-PCR was performed
in the linear range of amplification, (panel B), the end-point PCR products shown in panel (A) are only qualitative and well outside of the linear range.
(C) Immunoblot of an 8% urea-SDS polyacrylamide/Tris-glycine buffered gel loaded with 20 mg total protein/lane, using polyclonal anti-GFP antibody
(1:1000) and horse anti-rabbit secondary antibody (1:5000). The secondary antibody was conjugated to alkaline phosphatase and visualized with
BCIP/NBT. A single ,35kD immunoreactive band corresponding to GFP in ESCs (lane 1) and ESMVs (lane 2) was detected.
doi:10.1371/journal.pone.0004722.g003
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RNA II kit (Clontech) excludes small RNAs. Using equivalent
amounts of starting total RNA template, we detected a miR-16
signal only with the RNA samples containing small RNAs (not
shown). We then performed real time quantitative RT-PCR, using
Taqman Probes for detection, to quantify the abundance of
several miRNAs in ESMVs (Figure 5A). We chose to profile the
ubiquitously expressed miR-16, five ESC-specific miRNAs (miR-
290, miR-291-3p, miR-292-3p, miR-294, and miR-295) [23,24], and
two miRNAs that are upregulated in ESCs undergoing differen-
tiation (miR-21 and miR-22) [23,24]. We also included a small
nuclear RNA (RNU6b), which is usually used as a normalizer.
However, because of a large difference in RNU6b abundance in
ESCs and ESMVs, we were unable to use it as a normalizer in
these experiments. Instead, we performed our experiments using
equivalent amounts of total RNA template. Our results showed a
significant difference in relative abundance between several of the
ESC-specific miRNAs. Bootstrap ANOVA showed a significant
difference between all groups, F=0.69, p=0.008. Further analysis
using the 95th percentile confidence interval calculated for each
miRNA revealed differences between some groups (Figure 5B).
Non-overlapping groups at the 95% confidence interval are
significantly different from one another. Thus, based on the 95th
percentile confidence interval, it appears that RNU6b is signifi-
cantly less abundant than several of the miRNAs tested except
miR-22, miR-290, and miR-291. The relative abundance of all
tested miRNAs overlaps except for that of miR-295, which is
significantly more abundant than miR-290 and miR-291
(Figure 5B).
ESMVs fuse with other ES cells and transfer GFP
Previous studies demonstrated the transfer of endogenously
expressed proteins and RNA from microvesicles to cells. [6,10,25–
27]. To determine if ESMVs are capable of transferring
exogenously expressed GFP, we incubated ESCs without the GFP
transgene with ESMVs containing GFP. To better visualize the
cellular borders, the ESCs were pre-incubated with the lipophilic
dye, Vybrant DiD (Molecular Probes), prior to the addition of
ESMVs. After a three-hour incubation with ESMVs, the cells were
imaged by confocal microscopy. Cells that had been incubated with
ESMVs were clearly seen using the appropriate DiD filter set
(Figure 6A). The same cells were then imaged using the
corresponding filter to visualize GFP labeling (Figure 6B). Multiple
green vesicles can be seen docked on the ESCs (arrows) and several
patches of diffuse GFP signal can also be seen inside the cells near
the plasma membrane and in the cytoplasm (arrowheads,
Figure 6B.). Figure 6C was obtained by merging the images of
Figures 6A and 6B. Although the signal in the cytoplasm is not as
robust as the signal from the docked vesicles, the docking and fusion
of ESMVs to cells is highly efficient as the vast majority of cells
contain docked vesicles. DiD-labeled control ESCs incubated
without ESMVs (Figure 6D) did not show green fluorescence when
visualized with the GFP filter set (Figure 6E). Figure 6F was
obtained by merging the images of Figures 6D and 6E.
ESMVs fuse with MEFs and transfer miRNAs
The presence of miRNAs in ESMVs opens up the intriguing
possibility that miRNAs may be transferred by microvesicles. We
tested this hypothesis by incubating ESMVs with gamma-
irradiated MEFs and compared the level of miRNAs found in
MEFs alone with that of MEFs that had been incubated with
ESMVs. The abundance of several miRNAs (miR-290, miR-291-
3p, miR-292-3p, miR-294, and miR-295) increased in MEFs as
early as 1 hour after incubation, suggesting transfer. However, this
was not observed with all miRNAs tested. The ubiquitously
expressed miR-16 (and the small nuclear RNA, RNU6b) did not
transfer and remained near baseline at all time points tested
(Figure 7). In general, peak transfer occurred at nearly the same
time for all miRNAs capable of transfer, between 12–36 hours,
but although at 54 hours the levels of the transferred miRNAs had
not returned to baseline, they showed a significant downward
trend. The miRNAs that appeared to transfer most efficiently were
miRNAs found in abundance in ESCs but not in MEFs.
Discussion
The ability of a cell to signal nearby cells, and to sense their
local microenvironment, forms the basis for coordinated cellular
activity in multicellular organisms and is particularly important
during embryonic development. Early in development, embryo
Figure 4. The RNA in ESMVs is not degraded. Real time
quantitative RT-PCR was used to measure the level of degradation of
oct-4 and GFP mRNAs in ESMVs by comparing the 59 and 39 amplicon
ratios of these transcripts in ESMVs with those in ESCs. Significant levels
of degradation were not detected with either transcript. (A) Box plot of
normalized 59 and 39 template values for oct-4 mRNA in ESCs and
ESMVs (n = 9). (B) Box plot of normalized 59 and 39 template values for
GFP mRNA in ESCs and ESMVs (n = 12). The boxed area represents the
mean6quartile and the whiskers extend out to the minimum and
maximum values. Bootstrap t-tests were performed to compare the
59:39 ratios for each transcript in ESCs and ESMVs. No significant
difference was detected between the ESC group and ESMV group for
either transcript (p.0.1).
doi:10.1371/journal.pone.0004722.g004
Figure 5. ESMVs contain miRNAs. The relative abundance of several
miRNAs in ESMVs compared with ESCs was determined by real time
quantitative RT-PCR. The miRNAs tested include miR-16 (lane 1), miR-21
(lane 2), miR-22 (lane 3), miR-290 (lane 4), miR-291-3p (lane 5), miR-292-
3p (lane 6), miR-294 (lane 7), miR-295 (lane 8), and the small nuclear
RNA, RNU6b (lane 9). (A) Box plots of relative abundance in ESMVs
compared with ESCs (n = 9). The boxed area represents the mean6-
quartile and the whiskers extend out to the minimum and maximum
values. Bootstrap ANOVA was performed and a significant difference
was detected between all groups (p=0.008). (B) The 95th percentile
confidence interval for each miRNA was determined and plotted on a
bar graph. Non-overlapping groups are significantly different from each
other. RNU6b is significantly less abundant than all miRNAs tested
except for miR-22, miR-290, and miR-291. The majority of miRNAs tested
do not differ significantly from one another except for miR-295, which is
significantly more abundant than miR-290 and miR-291.
doi:10.1371/journal.pone.0004722.g005
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polarity is established so that the major axes (i.e. left-right, dorso-
ventral, rostro-caudal) can be defined. The development and
maintenance of polarity involves cell to cell communication [28]
and embryonic stem cells in the early blastocyst undoubtedly
communicate with one another. Traditional methods of intercel-
lular communication mediated by cell-cell or cell-intercellular
matrix contact involve gap junctions, secreted signaling molecules,
and physical interaction of membrane proteins. An alternative
method of intercellular communication involves microvesicles,
which have been demonstrated to transport proteins and mRNA
from cell to cell and also to transport surface ligands short
distances to interact with cells [5,6,9,10,25–27]. We now report
evidence of a novel method of intercellular communication
mediated by the transfer of miRNAs by microvesicles. Our
findings open up the possibility that miRNAs may also serve as
signaling molecules allowing for coordinated intercellular regula-
tion of gene expression. MiRNAs play important roles during
embryonic development [29–33]. It is interesting to think that
perhaps the intercellular transfer of specific miRNAs by
microvesicles may help establish embryo polarity and tissue
patterning by creating gradients of miRNAs.
Our results suggest that only certain miRNAs are efficiently
transferred to MEFs. Perhaps the transfer of miRNAs is an active
process, possibly regulated by proteins found in microvesicles or
receptors found on recipient cells. Alternatively, the abundance of
miRNAs may be tightly regulated by specific nucleases such that
miR-16 levels inside MEFs are kept within a specific range, but the
ESC specific miRNAs are not. In our experiments, we tested the
ability of ESMVs to transfer miRNAs to growth-arrested MEFs.
We can speculate that the efficiency of transfer may be different,
perhaps even enhanced, with rapidly dividing or proliferating cells
such as those found in a developing blastocyst. However, we have
not tested this hypothesis at this time. The ability of microvesicles
Figure 6. ESMVs transfer GFP. ESCs without the GFP transgene were labeled with DiD and then incubated with ESMVs containing GFP. All
confocal images were taken using a 1006, 1.4 NA objective with the pinhole set to 1 airy unit. (A) DiD signal from ESCs incubated with ESMVs. (B)
GFP signal from ESCs incubated with ESMVs. Arrows indicate punctate signal, likely representing docked vesicles. Arrowheads indicate diffuse signal,
likely from the diffusion of GFP inside the cell or from the production of newly translated GFP. (C) Overlay of A+B. (D) DiD signal from control ESCs
without ESMVs. (E) No GFP signal can be detected in the absence of ESMVs. (F) Overlay of D+E. All scale bars are 5 mm.
doi:10.1371/journal.pone.0004722.g006
Figure 7. ESMVs transfer miRNAs. MEFs were incubated with
ESMVs for 1, 12, 36, or 54 hours and transfer of miRNAs was determined
by real time quantitative RT-PCR (n = 5). Time point 0 represents MEFs
without ESMVs. The difference in Ct values between the negative
control (MEFs alone) and each experimental group (miR-290, miR-291-
3p, miR-292-3p, miR-294, miR-295, miR-16, and RNU6b) is shown.
Positive values indicate transfer of miRNA.
doi:10.1371/journal.pone.0004722.g007
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to transfer miRNAs is a novel finding which expands upon the
roles that miRNAs are thought to play.
Stem cell and tissue specific microvesicles are interesting
candidates for novel signaling factors in stem cell niches [34].
They are capable of carrying mRNAs, miRNAs, and proteins
short distances and would be ideal paracrine factors in the
microenvironments of stem cells. Ratajczak et al. [6] have already
demonstrated that ESMVs are capable of enhancing the
proliferation of hematopoietic progenitors. Our study shows that
microvesicles released from ESCs are capable of transferring not
only mRNA and protein, but also miRNAs to cells. Further study
of microvesicles and their contents, released from other stem and
progenitor cells may help elucidate the exact role that microves-
icles play within stem cell niches. If microvesicles are indeed
mediators of signaling in stem cell niches, they may be useful
targets to reactivate or modulate the behavior of quiescent stem
cells following injury.
The ability of microvesicles to transfer RNA and protein, and to
act as paracrine factors raises very exciting possibilities for
therapeutic uses. Cells engineered to express mRNA, siRNA, or
protein may be capable of delivering these macromolecules to local
cellular environments via microvesicles. These engineered cells can
be encapsulated to provide sustained local delivery. Since current
techniques for gene transfer use viral or synthetic agents as delivery
agents, their replacement by microvesicles released from autologous
transplants of engineered cells will offer the advantage of a virus-free
approach and make the prospects of gene therapy safer.
Materials and Methods
Ethics Statement
All experiments involving mice were carried out according to
protocols approved by the UCLA Animal Research Committee
and in accordance with the ARVO Statement for use of animals in
Ophthalmic and Vision Research.
Isolation of ESMV RNA and RT-PCR
ESCs expressing the GFP transgene under the control of the
chicken b-actin promoter were obtained from the laboratory of
Timothy Ley (Washington University, Saint Louis). We generated
a second ESC line derived from C57Bl/6 mice. ESCs were
maintained in feeder-free conditions using ESGRO complete
(Chemicon) serum-free medium supplemented with 1–5% FBS to
enhance proliferation.
To prepare for ESMV collection, ESCs were expanded under
serum-free and feeder-free conditions. 3.56106 cells were plated
on gelatin-coated T175 culture flasks. 48 hours after plating, the
media was collected and spun at 3500g for 30 minutes at 4uC to
pellet debris and fragmented cells. The supernatant was carefully
transferred to an ultracentrifuge tube and spun at 100,000g for
2 hours in a SW 28 or SW 40ti rotor at 4uC to pellet the
microvesicles. RNA was immediately frozen at 280uC in lysis
buffer from the mirVana miRNA isolation kit (Ambion), which
contains guanidinium thiocyanate, so that multiple samples could
be pooled together. When the desired number of samples was
collected, the RNA was isolated following Ambion’s protocol,
which retains small RNAs. To prepare samples excluding small
RNAs, we used the Nucleospin RNA II kit (Clontech) and
followed the manufacturer’s protocol. The RNA was quantified in
a Nanodrop ND-1000, analyzed by gel electrophoresis or
bioanalyzer (Agilent), and treated with TURBO DNAse (Ambion)
prior to further manipulation. RT-PCR was performed with
Improm-II RT (Promega) and the cDNA was amplified with
recombinant Taq polymerase (New England Biolabs). 35 cycles of
PCR in a non-linear, saturating range of amplification were
carried out with an annealing temperature of 60uC and an
extension time of 30 seconds using standard cycling conditions.
PCR products were analyzed by agarose gel electrophoresis. The
Dynabeads mRNA Purification Kit (Dynal Biotech) was used to
enrich the polyA-mRNA from total RNA.
Real time quantitative RT-PCR
Real time quantitative RT-PCR was performed using an
MX3000p instrument (Stratagene). DNase-treated total RNA
was reverse transcribed using Improm-II RT for mRNA or MuLV
RT (Applied Biosystems) for miRNAs. Detection with SYBR
Green (Stratagene) was used for mRNA assays and Taqman
probes (Applied Biosystems) for miRNA assays.
For all SYBR Green assays, standard curves were generated for
each primer set to determine their efficiency, and dissociation curves
were generated to detect non-specific amplification products and
primer-dimers. PCR products were also analyzed by agarose gel
electrophoresis to confirm that a single PCR product was produced.
A set of ‘‘no RT’’ controls were performed with each batch of RNA,
and no template controls were included with each experiment.
Standard curves were used to establish an initial template quantity
(absolute quantification) in determination of 59:39 ratios. The data
was normalized against the composite median of both 59 and 39
initial template values in order to plot the experiments on the same
scale, without altering the ratios. A normalizer was not necessary
since the same transcript from the same sample was amplified by
two sets of primers (59 or 39). Standard cycling conditions were used
with an annealing temperature of 60uC.
Comparative quantification of different mRNAs was performed
without a normalizer and thus, the 22DDCt method of quantifi-
cation [35] was not used. In order for a normalizer to be valid, it
must have the same copy number in both the control (calibrator)
sample and test sample (unknown), and we did not have any
mRNA with this characteristic. Thus, to compare the relative
abundance of mRNA transcripts in ESCs with ESMVs, we relied
on using equivalent amounts of ESC and ESMV total RNA in
each experiment. The ESC samples were set as calibrators for the
ESMV samples and corrections for primer efficiency were
performed using the MX Pro software (Stratagene). Comparative
quantification of miRNAs with Taqman probes was performed
using Taqman miRNA assays (Applied Biosystems) according to
the manufacturer’s protocol. The assays used were: hsa-miR-16,
hsa-miR-21, hsa-miR-22, mmu-miR-290, mmu-miR-291-3p,
mmu-miR-292-3p, mmu-miR-294, mmu-miR-295, and the small
nuclear RNA, RNU6b. We were unable to find a suitable
normalizer, thus the same method of quantification that was used
for mRNAs was also used for miRNAs.
Table 1 lists the non-commercial PCR primers used. For
quantitative comparison, the oct-4 and GFP 59 primer sets were
used. The commercially available primer sequences for the
Taqman assays can be downloaded from the manufacturer’s
website (http://www3.appliedbiosystems.com/cms/groups/por-
tal/documents/generaldocuments/cms052133.xls).
Isolation of ESMV protein and immunoblot
To isolate crude protein, the final ESMV pellet was incubated
on an agitator with digestion buffer (2% Triton X-100, 0.3%
CHAPS, 1mM PMSF in PBS) at 4uC to disrupt the membranes.
The insoluble fraction was pelleted by centrifugation at 20,0006g
for 1 hour at 4uC. The soluble fraction was collected and
precipitated with 20% trichloroacetic acid (TCA), washed twice
with ice-cold acetone and separated on a Tris-glycine buffered 4–
20% SDS-polyacrylamide gel.
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To detect GFP protein, the ultracentrifuged ESMV pellet was
resuspended in ice-cold cell disruption buffer from the mirVana
Paris kit (Ambion) and the total protein was quantified using the
Bradford assay. Crude protein preparations were stored frozen at
280uC or used immediately for analysis. Prior to loading, the
samples were heated to 87–90uC for 5 minutes in sample buffer
containing 0.2M DTT and 1.8M beta-mercaptoethanol. Total
protein (20 mg per sample) was separated on a 8%T/3%C, 6M
urea, SDS-polyacrylamide gel using a Tris/glycine buffer system,
and transferred to a PVDFmembrane overnight. GFP was detected
with 1:1000 diluted rabbit anti-GFP polyclonal antibodies (Molec-
ular Probes) and 1:5000 diluted horse anti-rabbit IgG conjugated to
alkaline phosphatase (Vector Labs). Immunoreactive bands were
visualized with 5-bromo-4-chloro-39-indolylphosphate p-toluidine
salt and nitro-blue tetrazolium chloride (BCIP/NBT).
Transfer of GFP to ES cells
Immediately after passaging, 200 ml of ESCs (,106 cells/mL)
were transferred to a culture tube in serum-free medium with 1 ml
of Vybrant DiD (Molecular Probes). The cells were incubated for
20 minutes at 37uC, and then washed 26 with pre-warmed
DMEM. After the last wash, the cells were resuspended in 200 ml
serum-free medium and separated into two tubes. An additional
100 ml of serum-free medium was added to one tube serving as
control and 100 ml of ESMVs containing GFP (collected from 3-4
T175 flasks) were added to the second tube. Both tubes were
incubated at 37uC for 3 hrs prior to imaging the cells on a Leica
TCS-SP inverted confocal microscope. Images were taken with a
1006, 1.4 NA plan apochromatic objective. Excitation was
achieved with the 488nm laser line for GFP and the 633nm laser
line for DiD. The spectral detector was set to 498–531nm for GFP
and 650–714nm for DiD detection. All images were taken with the
pinhole set to 1 airy unit. The DiD image was overlayed on the
GFP image after digitization using the Leica confocal software or
Adobe Photoshop CS2.
Transfer of miRNAs to embryonic fibroblasts
Approximately 1.66105 cells/well of gamma-irradiated MEFs
were pre-plated on 24 well plates at least 2 days prior to initiation
of the experiment. ESMVs isolated from 6 T175 flasks (as
described above) were divided evenly between all samples and co-
incubated with the pre-plated MEFs. Growth-arrested MEFs were
used to maintain a constant ratio of ESMVs to MEFs between
each experiment since we do not know if ESMVs have any effect
on the growth or proliferation of MEFs. Each experimental series
included a negative control (MEF only) and 4 experimental time
points (MEF+ESMVs). We collected MEFs after 1, 12, 36, and
54 hours. To collect the cells while removing free-floating ESMVs,
MEFs were washed with PBS twice prior to dissociation. MEFs
were then enzymatically dissociated from the plates and washed
two more times with PBS. After each wash, cells were spun down
at 35006g for 5 minutes so that any residual ESMVs would float
in the supernatant and be discarded. We isolated the MEF total
RNA and performed real time quantitative RT-PCR with a subset
of miRNAs using the protocol described above. As an indirect
measure of miRNA transfer, we determined the difference in Ct
values between the negative control and each experimental time
point; a positive value indicated transfer. If no signal was detected,
a Ct value of 40 was assigned to the sample.
Bootstrap statistics
Bootstrap statistics emulates real life by generating random and
independent data points from the original data set using computer-
intensive programs. All statistical analyses were performed using
Excel (Microsoft) and the Excel Add-in from Resampling Stats
software (Statistics.com) using standard methods [36]. For
bootstrap t-tests comparing the 59:39 ratio of ESCs with ESMVs,
the initial template values were normalized as described above.
Pseudogroups of the normalized values were randomly generated
with replacement and the 59:39 ratios were calculated from the
pseudogroup means. The difference between the 59:39 ratios for
ESMVs and ESCs was resampled 10,000 times and binned to
determine the 95th percentile confidence intervals for acceptance
of the null hypothesis. For bootstrap ANOVA, the pseudogroups
were generated from the relative quantity of each transcript or
miRNA tested. The medians of these pseudogroups were
resampled 10,000 times and binned to determine the 95th
percentile confidence intervals and for calculating the F-ratio.
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